ESC 365 - Evidence for antithrombotic therapy from trials.

EHRA Premium Access

Evidence for antithrombotic therapy from trials.

Session: Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis

Topic: Atrial fibrillation (AF)

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

44 presentations

3 followers

4 more presentations in this session

Epidemiology of valvular atrial fibrillation and implications for stroke/thromboembolism.

Speaker: Professor G. Boriani (Modena, IT)

Evidence for antithrombotic therapy from observational cohorts.

Speaker: Professor L. Fauchier (Tours, FR)

Mechanical heart valves, bioprostheses, TAVI.

Speaker: Professor J. Morais (Leiria, PT)

What the consensus document says.

Speaker: Professor G. Lip (Liverpool, GB)

Access the full session

Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis

Speakers: Associate Professor T. Potpara, Professor G. Boriani, Professor L. Fauchier, Professor J. Morais, Professor G. Lip

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources